As far as we know, the reason for springer's large-scale retraction of the journal Tumor Biology is fraud, or rather, peer review fraud. The concept of peer review should be familiar to people engaged in scientific research, that is, after an academic article is submitted, the publishing unit will let other experts and scholars in the same field review it to decide whether the manuscript can be hired and published. The purpose of this practice is to ensure that the author's work level meets the standards of general academic and disciplinary fields, which can be called the "foundation" of modern scientific research buildings.
The so-called peer review fraud means that the author wrote the real name of the reviewer, but invented the reviewer's email address, and the editor sent the paper to a fake email address, thus receiving the peer review of "100% approval" and allowing the unqualified paper to be published. This time, springer found that there were 65,438+007 institutional papers in China from 2065,438+02 to 2065,438+06, so he decided to withdraw the manuscript.
Peter Butler, editor-in-chief of Cell Biology and Biochemistry in pringle, made it clear in response to Shell. Many journals also admit that authors suggest peer reviewers.